Order Article Reprints

Bagheri-Yarmand R, Busaidy NL, McBeath E, Danysh BP, Evans KW, Moss TJ, Akcakanat A, Ng PKS, Knippler CM, Golden JA, et al. RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient. Cancers. 2021; 13(19):4950. https://doi.org/10.3390/cancers13194950

Bagheri-Yarmand, Rozita, Naifa L. Busaidy, Elena McBeath, Brian P. Danysh, Kurt W. Evans, Tyler J. Moss, Argun Akcakanat, Patrick K. S. Ng, Christina M. Knippler, Jalyn A. Golden, and et al. 2021. "RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient" Cancers 13, no. 19: 4950. https://doi.org/10.3390/cancers13194950

Bagheri-Yarmand, R., Busaidy, N. L., McBeath, E., Danysh, B. P., Evans, K. W., Moss, T. J., Akcakanat, A., Ng, P. K. S., Knippler, C. M., Golden, J. A., Williams, M. D., Multani, A. S., Cabanillas, M. E., Shaw, K. R., Meric-Bernstam, F., Shah, M. H., Ringel, M. D., & Hofmann, M. C. (2021). RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient. Cancers, 13(19), 4950. https://doi.org/10.3390/cancers13194950